12.300
−0,81%
2026-10-19
Fundamental Analysis
54 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +18.1% | +129.2% | 2 / 3 | +52.9% | +2.42 pp | -47.57 pp | +11.9% | 1.07 | 4.66 | 130 | +52,9% | 127 | +2,9% | 4.66 | 7.88 | −40,9% |
| Pts | 0 | 12 | 8 | 12 | 8 | 0 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 12.300 (close price on 2026-10-19)EPS (TTM): 2.639
Financial charts
1.Revenue & growth
VND bn130Q2/26
1.Revenue & growth
VND bn130Q2/26
2.Profit & growth
VND bn126Q2/26
3.Profit mix (Penman)
VND bn622Q2/26
4.Margins & cost structure
%47.3%Q2/26
5.Returns & cash cycle
% · days2.3%Q2/26
6.Earnings quality & cash
VND bn-724Q2/26
7.Asset structure
VND bn10.999Q2/26
8.Funding & debt health
VND bn · times10.999Q2/26
9.Revenue backlog
VND bn23,8Q2/26
10.Valuation
times · %5,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %592Q2/26
Adjusted EPS growth, latest quarter
18.1%
Average adjusted EPS growth, 3 quarters
129%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26